Home › Titan Spine Receives FDA Approval For Next Generation nanoLOCKTM Surface Technology
 

Keywords :   


Titan Spine Receives FDA Approval For Next Generation nanoLOCKTM Surface Technology

2014-11-14 08:05:49| surfacefinishing News Articles

Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endoskeleton line of interbody fusion implants featuring its next-generation nanoLOCKTM surface technology

Tags: technology generation surface approval

Category:Materials

Latest from this category

All news
»
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
25.06World's biggest music labels sue over AI copyright
25.06Hybrid Software wins FLAG Vendor Partner of the Year award
25.06Hospeco Purchases Nuance Solutions
25.06Atlantic Tropical Weather Outlook
More »